News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
817,099 Results
Type
Article (61656)
Company Profile (758)
Press Release (754666)
Multimedia
Podcasts (176)
Webinars (27)
Section
Business (226151)
Career Advice (3526)
Deals (38999)
Drug Delivery (148)
Drug Development (88864)
Employer Resources (193)
FDA (17995)
Job Trends (16909)
News (384238)
Policy (37502)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2975)
Academic (1)
Accelerated approval (40)
Adcomms (36)
Allergies (161)
Alliances (55164)
ALS (190)
Alzheimer's disease (1816)
Antibody-drug conjugate (ADC) (370)
Approvals (18197)
Artificial intelligence (619)
Autoimmune disease (186)
Automation (46)
Bankruptcy (403)
Best Places to Work (12552)
BIOSECURE Act (23)
Biosimilars (210)
Biotechnology (467)
Bladder cancer (172)
Brain cancer (68)
Breast cancer (691)
Cancer (5276)
Cardiovascular disease (463)
Career advice (3011)
Career pathing (43)
CAR-T (317)
CDC (64)
Celiac Disease (2)
Cell therapy (859)
Cervical cancer (38)
Clinical research (75443)
Collaboration (1934)
Company closure (5)
Compensation (1220)
Complete response letters (79)
COVID-19 (2987)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6615)
Decentralized trials (2)
Denatured (56)
Depression (159)
Diabetes (548)
Diagnostics (7273)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (300)
Drug pricing (228)
Drug shortages (35)
Duchenne muscular dystrophy (257)
Earnings (97682)
Editorial (69)
Employer branding (24)
Employer resources (168)
Events (133089)
Executive appointments (1065)
FDA (21324)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1618)
Gene editing (230)
Generative AI (56)
Gene therapy (706)
GLP-1 (1159)
Government (5354)
Grass and pollen (8)
Guidances (388)
Healthcare (20718)
HIV (74)
Huntington's disease (52)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (75)
Indications (128)
Infectious disease (3300)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (131)
Intellectual property (268)
Interviews (681)
IPO (17844)
IRA (61)
Job creations (4759)
Job search strategy (2435)
JPM (72)
Kidney cancer (19)
Labor market (92)
Layoffs (654)
Leadership (44)
Legal (9371)
Liver cancer (100)
Longevity (18)
Lung cancer (712)
Lymphoma (395)
Machine learning (47)
Management (64)
Manufacturing (898)
MASH (182)
Medical device (14981)
Medtech (15045)
Mergers & acquisitions (22257)
Metabolic disorders (1457)
mRNA (199)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (380)
Neuropsychiatric disorders (107)
Neuroscience (3216)
Neurotech (1)
NextGen: Class of 2026 (7548)
Non-profit (5024)
Now hiring (70)
Obesity (713)
Opinion (346)
Ovarian cancer (171)
Pain (225)
Pancreatic cancer (250)
Parkinson's disease (313)
Partnered (37)
Patents (539)
Patient recruitment (545)
Peanut (64)
People (65441)
Pharmaceutical (135)
Pharmacy benefit managers (34)
Phase 1 (23509)
Phase 2 (33015)
Phase 3 (24738)
Pipeline (5952)
Policy (356)
Postmarket research (2991)
Preclinical (10122)
Press Release (71)
Prostate cancer (269)
Psychedelics (60)
Radiopharmaceuticals (315)
Rare diseases (996)
Real estate (6989)
Recruiting (78)
Regulatory (27718)
Reports (59)
Research institute (2698)
Resumes & cover letters (555)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (27)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (174)
Sponsored (48)
Startups (4217)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (101)
The Weekly (118)
Vaccines (1178)
Venture capital (101)
Weight loss (486)
Women's health (102)
Worklife (23)
Date
Today (4)
Last 7 days (930)
Last 30 days (2906)
Last 365 days (32063)
2026 (5240)
2025 (32448)
2024 (37804)
2023 (42494)
2022 (53876)
2021 (58616)
2020 (57446)
2019 (50888)
2018 (38690)
2017 (36227)
2016 (36724)
2015 (42728)
2014 (36955)
2013 (32209)
2012 (34266)
2011 (34534)
2010 (32854)
Location
Africa (1061)
Alabama (95)
Alaska (7)
Arizona (345)
Arkansas (15)
Asia (47509)
Australia (8010)
California (12097)
Canada (3437)
China (1221)
Colorado (509)
Connecticut (523)
Delaware (357)
Europe (107181)
Florida (1799)
Georgia (392)
Hawaii (4)
Idaho (65)
Illinois (988)
India (79)
Indiana (569)
Iowa (24)
Japan (460)
Kansas (134)
Kentucky (46)
Louisiana (30)
Maine (84)
Maryland (1489)
Massachusetts (8866)
Michigan (369)
Minnesota (678)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (87)
New Jersey (3252)
New Mexico (33)
New York (3195)
North Carolina (1663)
North Dakota (10)
Northern California (5864)
Ohio (373)
Oklahoma (23)
Oregon (53)
Pennsylvania (2409)
Puerto Rico (25)
Rhode Island (52)
South America (1459)
South Carolina (70)
South Dakota (1)
Southern California (4690)
Tennessee (184)
Texas (1893)
United States (43440)
Utah (367)
Vermont (1)
Virginia (302)
Washington D.C. (88)
Washington State (1004)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
817,099 Results for "the liposome company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Cell Therapy
6 Companies Hanging On in Cell Therapy
As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, these players are sticking around to take the modality as far as it can go.
December 1, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
February 11, 2026
·
6 min read
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
February 24, 2026
·
4 min read
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
·
3 min read
Press Releases
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
February 1, 2026
·
8 min read
Press Releases
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
February 25, 2026
·
8 min read
Press Releases
TurnCare, Inc. Announces New Leadership Appointments to Advance Company’s Transition to Commercial Organization
December 10, 2025
·
2 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
1 of 81,710
Next
